MAVRILIMUMAB Drug Record

  • MAVRILIMUMAB chembl:CHEMBL1743039

    Alternate Names:

    MAVRILIMUMAB
    CAM3001
    CAM-3001

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antiinflammatory agent,DMARD
    (0 More Sources)

    Publications:

  • MAVRILIMUMAB   CSF2RA

    Interaction Score: 10.3

    Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:
    Trial Name CAM-3001
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial TTD

  • MAVRILIMUMAB   CSF2

    Interaction Score: 0.75

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    TTD

  • TdgClinicalTrial: CAM-3001

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antiinflammatory agent,DMARD
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

  • TTD: Mavrilimumab

    • Version: 2020.06.01

    Alternate Names:
    D06KCF TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1743039

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: